These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4157558)

  • 21. Botulinum-A toxin: an exciting new treatment option for prostatic disease.
    Thomas CA; Guercini F; Chuang YC; Chancellor MB
    Int J Clin Pract Suppl; 2006 Dec; (151):33-7. PubMed ID: 17169009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Minocycline and doxycycline concentrations in the serum, urine, prostatic fluid and prostatic tissue].
    Friesen A; Streifinger W; Hofstetter A; Rothenberger K; Adam D
    Fortschr Med; 1982 Apr; 100(13):605-8. PubMed ID: 6178665
    [No Abstract]   [Full Text] [Related]  

  • 23. Promise for prostatitis?
    Wyllie MG
    BJU Int; 2005 Nov; 96(7):1137-8. PubMed ID: 16225543
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of raveron and levorin on urination recovery in prostatic adenoma and chronic prostatitis].
    Savin VF; Antonov NM; Arkannikov AB
    Urol Nefrol (Mosk); 1982; (2):22-4. PubMed ID: 6177084
    [No Abstract]   [Full Text] [Related]  

  • 25. [Efficacy of vitaprost forte in patients with prostatic adenoma].
    Miller AM; Iaroshenko VP; Soroka PV; Stakhnev EIu
    Urologiia; 2008; (5):50, 52-4. PubMed ID: 19069497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A trial of using EHF therapy in patients with benign prostatic hyperplasia and its combination with chronic prostatitis].
    Loran OB; Dunaevskiĭ IaL; Segal AS
    Urol Nefrol (Mosk); 1996; (6):37-9. PubMed ID: 9036608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The application of botulinum toxin in the prostate.
    Chuang YC; Chancellor MB
    J Urol; 2006 Dec; 176(6 Pt 1):2375-82. PubMed ID: 17085104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Penetrability and therapeutic effect of vancomycin to the prostates of rats with bacterial prostatitis (BP) or BPH-BP].
    Wang H; Chen ZH; Zhu YY; Wang T; Wu XJ
    Zhonghua Nan Ke Xue; 2006 Jun; 12(6):490-5. PubMed ID: 16833184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Conservative and surgical management of prostatic diseases].
    Hubmann R; Opelt B
    Internist (Berl); 1968 May; 9(5):207-13. PubMed ID: 4178136
    [No Abstract]   [Full Text] [Related]  

  • 30. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
    Wu XJ; Yang LY; Zhang XZ
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation report on spasmo-urgenin. A new urospasmolytic].
    Schöll H; Reinhofer E
    Med Welt; 1971 Mar; 12():471-3. PubMed ID: 4104508
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cernilton in the treatment of prostatic adenoma and chronic prostatitis].
    Aslamazov EG; Akhvlediani ND; Vinarov AZ; Aliaev IuG
    Urologiia; 2007; (1):52, 54-6. PubMed ID: 17472001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of clarithromycin in the prostate: implications for the treatment of chronic abacterial prostatitis.
    Giannopoulos A; Koratzanis G; Giamarellos-Bourboulis EJ; Panou C; Adamakis I; Giamarellou H
    J Urol; 2001 Jan; 165(1):97-9. PubMed ID: 11125373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Finasteride in prolonged therapy of patients with benign prostatic hyperplasia].
    Mazo EB
    Urologiia; 2001; (3):20-2. PubMed ID: 11505535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ampicillin concentration in prostatic tissue and prostatic fluid.
    Wolf H; Madsen PO; Rhodes P
    Urol Int; 1967; 22(5):453-60. PubMed ID: 4170116
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of diseases of the lower urinary tract and male adnexa. Trials with Spasmo-Urogenin].
    Hofstetter A; Eisenberger F
    Munch Med Wochenschr; 1968 Mar; 110(10):619-22. PubMed ID: 4178734
    [No Abstract]   [Full Text] [Related]  

  • 37. [Optimal treatment of benign prostatic hyperplasia (BPH) with comorbid chronic prostatitis (category IIIA)].
    Golubchikov VA; Sitnikov NV; Kochetov AG; Perekhodov SN; Sidorov OV; Roiuk RV; Nagoprniuk VN; Tsibizov DN
    Urologiia; 2005; (4):9-12. PubMed ID: 16158737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical approach to the prostate: an update.
    Kutikov A; Guzzo TJ; Malkowicz SB
    Radiol Clin North Am; 2006 Sep; 44(5):649-63, vii. PubMed ID: 17030218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hydrotherapy in the home in chronic bladder and prostate diseases].
    SCHOLTZ HG
    Arch Phys Ther (Leipz); 1962; 14():391-2. PubMed ID: 13992335
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibiotic pharmacokinetics in the inflamed prostate.
    Nickel JC; Downey J; Clark J; Ceri H; Olson M
    J Urol; 1995 Feb; 153(2):527-9. PubMed ID: 7815638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.